Case Study Analysis and Solutions

Case ID: 712049

Abstract:
Case Solution & Analysis for GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships by Arthur A. Daemmrich, Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric pneumonia) at fixed prices even as it transferred technology and know-how to Brazil for eventual domestic production. At the same time, GSK was co-sponsoring research into a new vaccine for Dengue fever with the Brazilian government. GSK's management must consider whether the PPP provides strategic advantage to its consumer healthcare businesses in Brazil and to access other emerging markets as well as the risks posed by the aggressive product obsolescence built into the technology transfer agreement.
Keywords:
Business & government relations, Foreign investment, Global business, Health, Health care, Health care policy, International business, Investments, Management, Technology, GlaxoSmithKline in Brazil Public-Private Vaccine Partnerships Case Solution

Click Here to place your order

OR

Contact us directly at ordercasesolutions@gmail.com if you want to solve the above case.